MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Multiple system atrophy(MSA): Clinical features"

  • 2019 International Congress

    Three-year follow-up of a patient with a rare combination of taupathy (PSP) and synucleopathy (MSA)

    D. Aygun (Samsun, Turkey)

    Objective: We couldn't find an article showing that MSA and PSP appeared simultaneously in the same patient in the english literature. We wanted to present…
  • 2019 International Congress

    To compare early / late onset MSA from the PAN American MSA (PANMSA) database

    M. Cesarini, E. Gatto, J. Etcheverry, G. da Prat, F. Peralta (Caba, Argentina)

    Objective: Compare two different cohorts of patients with the same pathology differentiated by age of onset. Background: Multiple system atrophy (MSA) is a rare neurodegenerative…
  • 2019 International Congress

    Multiple System Atrophy: phenotypic spectrum approach coupled with brain FDG PET

    A. Eusebio, E. Guedj, JP. Azulay, M. Renaud, M. Boucekine, S. Grimaldi (Marseille, France)

    Objective: This study attempts to identify different phenotypes of patients with MSA and to describe corresponding brain 18-FDG Positron Emission Tomography (PET) patterns. Background: In…
  • 2019 International Congress

    Availability of levodopa and clinicopathological features of patients with multiple system atrophy

    C. Ishida, K. Komai, K. Takahashi, Y. Motozaki, A. Tagami, S. Shibata, M. Asakawa (Kanazawa, Japan)

    Objective: To investigate the availability of levodopa for pathologically confirmed multiple system atrophy (MSA) patients and determine the clinicopathological features of levodopa responders with MSA.…
  • 2019 International Congress

    Baseline analysis of PROSPECT-M-UK: a longitudinal study of PSP, CBS and MSA

    E. Jabbari, J. Woodside, V. Chelban, A. Costantini, N. Holland, N. Leigh, D. Burn, N. Pavese, A. Gerhard, C. Kobylecki, M. Hu, A. Church, J. Rohrer, H. Houlden, J. Rowe, H. Morris (London, United Kingdom)

    Objective: To complete the baseline analysis of clinical data from the PROSPECT-M-UK study and to assess the impact of applying current MDS PSP diagnostic criteria…
  • 2018 International Congress

    Non-motor symptoms in patients from the Catalonian Multiple System Atrophy Registry (CMSAR)

    D.M. Giraldo, A. Pérez Soriano, J. Rios Guillermo, E. Muñoz, Y. Compta, J. Pagonabarraga, F. Valldeoriola, J. Hernández-Vara, S. Jauma Classen, V. Puente, C. Pont, N. Caballol, E. Tolosa, A. Bayes, J. Campdelacreu, O. Fabregues, A. Avila, M. Calopa, C. Gaig, N. Fabregat, P. Pastor, M. Aguilar, M. Pujol, L. Planellas, A. Camara, M.J. Marti (Barcelona, Spain)

    Objective: To assess non-motor symptoms (NMS) and their demographic and clinical correlates in MSA patients included in the CMSAR. Background: NMS are an important and…
  • 2018 International Congress

    Peripheral immune activation was associated with multiple system atrophy

    B. Cao, XP. Chen, WH. Feng, QQ. Wei, LY. Zhang, HF. Shang (Chengdu, China)

    Objective: Our aim is to clarify the correlations between peripheral immune activation and the prevalence as well as the disease severity of MSA. Background: Alpha-synuclein…
  • 2018 International Congress

    Cognitive impairment in multiple system atrophy: A Nepalese tertiary center study

    R. Ojha, K. Oli (Kathmandu, Nepal)

    Objective: This study was done to describe the clinical profile of MSA and evaluate the cognitive function using mini-mental state examination(MMSE). Background: Multiple system atrophy…
  • 2018 International Congress

    Disease progression and survival of multiple system atrophy: A prospective French cohort study

    A. Foubert-Samier, A. Pavy-Letraon, F. Guillet, C. Helmer, M. LeGoff, F. Tison, F. Rascol, C. Proust-Lima, W. Meissner (Bordeaux, France)

    Objective: We report the first prospective natural history study of MSA combining progression of the disease and mortality. Background: Multiple system atrophy (MSA) is a…
  • 2018 International Congress

    Probable MSA presenting initially with urinary retention

    S. Simeoni, R. Sakakibara, J. Panicker (London, United Kingdom)

    Objective: We describe 6 cases of probable MSA presenting with urinary retention/incomplete bladder emptying. Background: MSA is a progressive neurodegenerative adult-onset disease whose clinical features…
  • « Previous Page
  • 1
  • …
  • 10
  • 11
  • 12
  • 13
  • 14
  • …
  • 20
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley